This propensity-score matched study may be a foretaste of the SMART trial that will be presented at ACC this week. Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.…

Any crystal ball predictions as to how this will differ from the results of the SMART trial being presented at ACC next month?

Self-expanding (SE) Evolut PRO vs balloon-expandable (BE) SAPIEN ULTRA in small annuli:
🔸 SE - superior hemodynamic performance (gradients, PPM)
🔸 BE - less PVL, PPI, stroke

📎 bit.ly/3vntMHB #JACCINT #vhdAS #TAVI

💥TAVR in Small Annuli: SAPIEN ULTRA vs. Evolut PRO
JACC Journals

🌐A SMART Trial-like design in a Real-World TAVR Registry

🔗 doi.org/10.1016/j.jcin…

Azeem Latib Matteo Sturla GCosta Marco Barbanti
Montefiore Health System Albert Einstein College of Medicine - Official

⏳ What will the SMART RCT show American College of Cardiology?

Just out! Coronary overlap w/ commissural alignment in #TAVR is <3% in CT modeling; coronary alignment rarely need.
JACC Journals #JACCINT by Mount Sinai Fuster Heart Hospital
Dr. Manish Vinayak MD DM FSCAI Parasuram Krishnamoorthy MD et al
jacc.org/doi/10.1016/j.………
@Khera_MD David J. Cohen, MD, MSc MIЯVΛƬ #IC Didier Tchetche

In the RE-ACCESS 2 Study unsuccessful coronary cannulation after #Evolut and #Acurate implanted with commissural alignment was 5.5%. Acurate still better than Evolut, but Remarkable improvement compared with RE-ACCESS.Commissural alignment in #TAVI matters JACC Journals

This comprehensive review aims to shed light on dyslipidemia management stratifying effectiveness of novel and advancing lipid-lowering therapy. Available now online on JCM MDPI

mdpi.com/2077-0383/13/5…

Federica Agnello Marco Barbanti
#dyslipidemia #cardiology #jcm #mdpi #lipid

Our recent study on PCI timing strategies in patients undergoing TAVI was among the most impactful articles in EuroIntervention 2023!

Great collaborative work! This is a tribute to all co-workers involved in this project ! Marco Barbanti Giuliano Costa Michael Joner

#PCRLV 2023 🇬🇧

Bringing the “patient” in #SimulationLab learning room for our session on coronary access after #TAVI ❤️ Marco Barbanti Arif Khokhar Martin Swaans

#CardioTwitter #CardioEd #MedEd #vhdAS #cvVHD #TAVR

Coronary Access after TAVI

Multi-modality teaching using:

⚙️ SIM
🫀 Real valves,
🐷 Real hearts,
📺 Smart screen and
Smart people 🤓
Marco Barbanti Alessandro Beneduce @martinandreas

Education. Revolution. #PCRLV23

#PCRLV coronary access during #TAVR with Alessandro Beneduce Marco Barbanti PCRonline 🫀 simulation learning room is packed 🌟🌟 Edoardo Zancanaro MD Alessandro Sticchi Jonathan Curio Andrea Scotti Victoria Delgado francesco maisano

1-year outcomes OPERA-TAVI registry finally out!
👉 No differences in mortality and re-hosp
👉Higher disabling stroke in Evolut PRO/PRO+ (2.6% vs. 0.4%). Selection bias? Real THV effect?
It is time for more RCTs! #TAVI
EuroIntervention Giuliano Costa eurointervention.pcronline.com/article/one-ye…

In the OPERA-TAVI registry, matched patients undergoing TAVI using Evolut PRO/PRO+ and Sapien 3 ULTRA devices exhibited comparable rates of the composite endpoint of all-cause mortality, rehospitalisation for heart failure, or disabling stroke at 1 year. eurointervention.pcronline.com/article/one-ye…

Long-term TAVI perspectives in a nutshell. #TAVI #TAVR Nature Reviews Cardiology John Webb nature.com/articles/s4156…

Where everything started! #GPUTeam !

🤔 What are the consistencies, discrepancies and gaps in the 🇺🇸 and 🇪🇺 Guidelines for VHD Management?

➡️ Happy to share with you the latest article from the EuroValve Consortium published in JACC Journals

🌐 sciencedirect.com/science/articl… European Society of Cardiology EACTS ACC Media Center AHA Science

Check out our new paper about the clinical outcomes of percutaneous management of non-calcified aortic regurgitation with Myval BEV in EuroIntervention eurointervention.pcronline.com/article/clinic… Ignacio J. Amat Pedro Martín Lorenzo Angel Schez-Recalde Manuel Pan Marco Barbanti Pablo Lamelas 🇦🇷🇨🇦 European Society of Cardiology PCRonline 🫀

Our #EAPCI PCR Journal Club review of the REVASC-TAVI ❤️

Omar Oliva PCRonline 🫀 EuroIntervention #CardioTwitter #CardioEd #TAVR #PCI #cvVHD #vhdAS #cvCAD

In patients with severe AS and stable CAD scheduled for TAVI, performance of PCI after TAVI seems to be associated with improved 2-year clinical outcomes compared with other revascularisation timing strategies. ow.ly/5Jlc50PiHOI

Read this study from the #NEOPRO registries now on JACC Journals

💡New PPI after TAVR is associated w/ higher 1-year mortality
💡This is particularly evident if LVEF <40%

🌐 doi.org/10.1016/j.jcin…

MPagnesi antonio mangieri Azeem Latib
Montefiore Heart